(1093:HK) –
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$7 at HSBC, 'pressure on DMS and NBP still exists in the medium term'
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Raised to HK$9.41 at Nomura/Instinet
-
Citi Reiterates Buy Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$8.20 at Jefferies
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$8.98 at Nomura/Instinet
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$12.50 at CLSA
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$8 at HSBC
-
Bernstein Reiterates Market Perform Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
Citi Reiterates Buy Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$11.70 at Credit Suisse
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$9.04 at Nomura/Instinet
-
CLSA Reiterates Buy (1) Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
Nomura/Instinet Reiterates Buy Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$10.18 at Goldman Sachs
-
Macquarie Starts CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) at Outperform
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$10.60 at Jefferies
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$12.40 at Credit Suisse
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$13 at Citi
-
Goldman Sachs Reiterates Buy Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
Bernstein Reiterates Market Perform Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$10.63 at Nomura/Instinet
-
CLSA Reiterates Buy (1) Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
CLSA Reiterates Buy (1) Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Raised to HK$13 at Credit Suisse
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Raised to HK$11.27 at Nomura/Instinet
-
CLSA Reiterates Buy (1) Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
Citi Reiterates Buy Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
Credit Suisse Reiterates Outperform Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$10.87 at Goldman Sachs
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Raised to HK$17.20 at CLSA
-
Citi Reiterates Buy Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$11.50 at Credit Suisse
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$11.20 at Nomura/Instinet
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$12 at Credit Suisse
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$11.64 at Nomura/Instinet
-
Citi Reiterates Buy Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
CLSA Reiterates Buy (1) Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
Credit Suisse Reiterates Outperform Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Raised to HK$12 at CLSA
-
Nomura/Instinet Reiterates Buy Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
Morgan Stanley Reiterates Overweight Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$12 at Morgan Stanley
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Lowered to HK$12.90 at Goldman Sachs
-
Credit Suisse Reiterates Outperform Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
Credit Suisse Reiterates Outperform Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
Credit Suisse Reiterates Outperform Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
Credit Suisse Reiterates Outperform Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
Goldman Sachs Reiterates Buy Rating on CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF)
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Raised to HK$13.50 at Goldman Sachs
-
CSPC Pharmaceutical Group Ltd. (1093:HK) (CHJTF) PT Raised to HK$14 at Credit Suisse
Back to 1093:HK Stock Lookup